Abstract
AbstractOsteoclasts (OCs), the only cells capable of remodeling bone, can demineralize calcium minerals biologically. Naive OCs have limitations for the removal of ectopic calcification, such as in heterotopic ossification (HO), due to their restricted activity, migration and poor adhesion to sites of ectopic calcification. HO is the formation of pathological mature bone within extraskeletal soft tissues, and there are currently no reliable methods for removing these unexpected calcified plaques. In the present study, we develop a chemical approach to modify OCs with tetracycline (TC) to produce engineered OCs (TC-OCs) with an enhanced capacity for targeting and adhering to ectopic calcified tissue due to a broad affinity for calcium minerals. Unlike naive OCs, TC-OCs are able to effectively remove HO both in vitro and in vivo. This achievement indicates that HO can be reversed using modified OCs and holds promise for engineering cells as “living treatment agents” for cell therapy.
Funder
The National Natural Science Foundation of China
National Key R&D Program
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference55 articles.
1. Blair, H., Teitelbaum, S., Ghiselli, R. & Gluck, S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245, 855–857 (1989).
2. Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337 (2003).
3. Cackowski, F. C. & Roodman, G. D. Perspective on the osteoclast. Ann. N. Y. Acad. Sci. 1117, 12–25 (2007).
4. Phan, T., Xu, J. & Zheng, M. Interaction between osteoblast and osteoclast: impact in bone disease. Histol. Histopathol. 19, 21643 (2004).
5. Doherty, T. M. et al. Rationale for the role of osteoclast-like cells in arterial calcification. FASEB J. 16, 577 (2002).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献